Jarman M - Search Results

1

Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer.

O'Donnell A, Judson I, Dowsett M, Raynaud F, Dearnaley D, Mason M, Harland S, Robbins A, Halbert G, Nutley B, Jarman M. O'Donnell A, et al. Among authors: jarman m. Br J Cancer. 2004 Jun 14;90(12):2317-25. doi: 10.1038/sj.bjc.6601879. Br J Cancer. 2004. PMID: 15150570 Free PMC article. Clinical Trial.

2

Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouse.

Nutley BP, Raynaud FI, Wilson SC, Fischer PM, Hayes A, Goddard PM, McClue SJ, Jarman M, Lane DP, Workman P. Nutley BP, et al. Among authors: jarman m. Mol Cancer Ther. 2005 Jan;4(1):125-39. Mol Cancer Ther. 2005. PMID: 15657360

3

Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.

Dowsett M, MacNeill F, Mehta A, Newton C, Haynes B, Jones A, Jarman M, Lonning P, Powles TJ, Coombes RC. Dowsett M, et al. Among authors: jarman m. Br J Cancer. 1991 Nov;64(5):887-94. doi: 10.1038/bjc.1991.420. Br J Cancer. 1991. PMID: 1931611 Free PMC article. Clinical Trial.

4

Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase).

Barrie SE, Potter GA, Goddard PM, Haynes BP, Dowsett M, Jarman M. Barrie SE, et al. Among authors: jarman m. J Steroid Biochem Mol Biol. 1994 Sep;50(5-6):267-73. doi: 10.1016/0960-0760(94)90131-7. J Steroid Biochem Mol Biol. 1994. PMID: 7918112

5

The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance.

Johnston SR, Riddler S, Haynes BP, A'Hern R, Smith IE, Jarman M, Dowsett M. Johnston SR, et al. Among authors: jarman m. Br J Cancer. 1997;75(6):804-9. doi: 10.1038/bjc.1997.144. Br J Cancer. 1997. PMID: 9062399 Free PMC article.

6

Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer.

Haynes BP, Jarman M, Dowsett M, Mehta A, Lønning PE, Griggs LJ, Jones A, Powles T, Stein R, Coombes RC. Haynes BP, et al. Among authors: jarman m. Cancer Chemother Pharmacol. 1991;27(5):367-72. doi: 10.1007/BF00688859. Cancer Chemother Pharmacol. 1991. PMID: 1847846

7

Pre-clinical development of the anti-tumour agent CB 7646, bis N-(hydroxymethyl) trimethylmelamine, a stable analogue of trimelamol.

Coley HM, Jarman M, Brooks N, Kubota T, Goddard PM, Jones M, Lee N, Owens MD, Halbert GW, Judson IR. Coley HM, et al. Among authors: jarman m. Int J Cancer. 1996 Nov 4;68(3):356-63. doi: 10.1002/(SICI)1097-0215(19961104)68:3<356::AID-IJC14>3.0.CO;2-6. Int J Cancer. 1996. PMID: 8903478 Free article.

8

Stable analogues of the antitumour agent trimelamol retain in vitro cytotoxicity in drug-sensitive and resistant rodent and human cell lines.

Coley HM, Jarman M, Brooks N, Thornton TJ, Judson IR. Coley HM, et al. Among authors: jarman m. Eur J Cancer. 1994;30A(12):1827-36. doi: 10.1016/0959-8049(94)00323-w. Eur J Cancer. 1994. PMID: 7880614

9

Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.

Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, Grimshaw R, Jarman M, Dowsett M. Johnston SR, et al. Among authors: jarman m. Cancer Res. 1999 Aug 1;59(15):3646-51. Cancer Res. 1999. PMID: 10446976

10

A cancer research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen.

Johnston SR, Gumbrell LA, Evans TR, Coleman RE, Smith IE, Twelves CJ, Soukop M, Rea DW, Earl HM, Howell A, Jones A, Canney P, Powles TJ, Haynes BP, Nutley B, Grimshaw R, Jarman M, Halbert GW, Brampton M, Haviland J, Dowsett M, Coombes RC; Cancer Research UK Phase I/II Committee. Johnston SR, et al. Among authors: jarman m. Cancer Chemother Pharmacol. 2004 Apr;53(4):341-8. doi: 10.1007/s00280-003-0733-6. Epub 2004 Jan 13. Cancer Chemother Pharmacol. 2004. PMID: 14722733 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

284 results

Search Page